Europe • Euronext Paris • EPA:ALVIO • FR0010095596
We assign a fundamental rating of 0 out of 10 to ALVIO. ALVIO was compared to 84 industry peers in the Biotechnology industry. ALVIO may be in some trouble as it scores bad on both profitability and health. ALVIO has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -64.42% | ||
| ROE | N/A | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.34% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.26 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.35 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.25 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 0 / 10 to ALVIO.PA.
ChartMill assigns a valuation rating of 1 / 10 to VALERIO TX (ALVIO.PA). This can be considered as Overvalued.
VALERIO TX (ALVIO.PA) has a profitability rating of 0 / 10.
The financial health rating of VALERIO TX (ALVIO.PA) is 0 / 10.
The Earnings per Share (EPS) of VALERIO TX (ALVIO.PA) is expected to grow by 23.08% in the next year.